How to cite item

Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

   
@article{TLCR28867,
	author = {Biagio Ricciuti and Giuseppe Lamberti and Fausto Roila and Giulio Metro},
	title = {Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option},
	journal = {Translational Lung Cancer Research},
	volume = {8},
	number = {Suppl 4},
	year = {2019},
	keywords = {},
	abstract = {Rearrangements of the anaplastic lymphoma kinase (ALK) gene occur in approximately 5% of non-small cell lung cancers (NSCLCs), in which they identify a distinct subtype of lung tumor that shows exquisite sensitivity to therapy with ALK tyrosine kinase-inhibitors (ALK-TKIs) (1).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/28867}
}